a year ago
CRBP
AnalystsJeff JonesJeff Jones's Stock Forecasts
AnalystsJeff Jones
Analyst Ranking
Bottom 23%
#3832 out of 4929 analysts
Average Return
-0.13%
Win Rate
29%28 out of 97
Risk vs Reward
Poor
Good
Jeff Jones's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Corbus Pharmaceuticals Holdings IncCRBP | +771.54% | $6.15 | $53.60 | 2023-08-08 - 2024-08-08 | Buy |
Fusion Pharmaceuticals IncFUSN | +728.85% | $2.60 | $21.55 | 2023-09-28 - 2024-06-03 | Buy |
Corbus Pharmaceuticals Holdings IncCRBP | +369.82% | $9.31 | $43.74 | 2023-05-09 - 2024-05-09 | Buy |
Prometheus Biosciences IncRXDX | +235.61% | $59.57 | $199.92 | 2022-10-03 - 2023-06-15 | Buy |
Perspective Therapeutics IncCATX | +229.22% | $4.86 | $16.00 | 2023-05-18 - 2024-05-17 | Buy |
Jeff Jones Analyst Color
Get additional color on Jeff Jones's coverage of popular stocks
Jeff Jones's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Kymera Therapeutics IncKYMR | 5 | Buy | $53.00 | +18.33% | Maintains | 8 days ago |
Arrivent Biopharma IncAVBP | 3 | Buy | $44.00 | +111.84% | Maintains | 11 days ago |
Y Mabs Therapeutics IncYMAB | 3 | Buy | $15.00 | +248.84% | Maintains | a month ago |
Chemomab Therapeutics LtdCMMB | 6 | Buy | $10.00 | +762.07% | Maintains | 2 months ago |
Alumis IncALMS | 2 | Buy | $25.00 | +635.29% | Maintains | 2 months ago |
Zura Bio LtdZURA | 4 | Buy | $17.00 | +1,404.42% | Maintains | 2 months ago |
Corvus Pharmaceuticals IncCRVS | 5 | Buy | $17.00 | +330.38% | Reiterates | 2 months ago |
Immunocore Holdings PLCIMCR | 2 | Buy | $86.00 | +160.45% | Maintains | 2 months ago |
Corbus Pharmaceuticals Holdings IncCRBP | 9 | Buy | $56.00 | +626.33% | Maintains | 2 months ago |
Evolent Health IncEVH | 4 | Buy | $18.00 | +52.67% | Maintains | 5 months ago |
Perspective Therapeutics IncCATX | 6 | Buy | $16.00 | +334.78% | Maintains | 7 months ago |
Cellectar Biosciences IncCLRB | 4 | Buy | $360.00 | +7,400.00% | Maintains | 8 months ago |
Ventyx Biosciences IncVTYX | 9 | Buy | $9.00 | +332.69% | Reiterates | 8 months ago |
Pliant Therapeutics IncPLRX | 6 | Buy | $45.00 | +3,471.43% | Maintains | a year ago |
Seres Therapeutics IncMCRB | 3 | Buy | $80.00 | N/A | Maintains | a year ago |
Patterson Companies IncPDCO | 3 | Hold | $30.00 | N/A | Maintains | a year ago |
Fusion Pharmaceuticals IncFUSN | 3 | Buy | $15.00 | N/A | Maintains | a year ago |
Cyclacel Pharmaceuticals IncCYCC | 3 | Buy | $1,920.00 | N/A | Maintains | 2 years ago |
Point Biopharma Global IncPNT | 2 | Buy | $13.00 | N/A | Reiterates | 2 years ago |
Novan IncNOVNQ | 2 | Buy | $8.00 | N/A | Maintains | 2 years ago |
Pmv Pharmaceuticals IncPMVP | 5 | Buy | $15.00 | N/A | Reiterates | 2 years ago |
An2 Therapeutics IncANTX | 1 | Buy | $24.00 | N/A | Maintains | 2 years ago |
Moleculin Biotech IncMBRX | 2 | Buy | $75.00 | N/A | Reiterates | 2 years ago |
Prometheus Biosciences IncRXDX | 6 | Buy | $150.00 | N/A | Maintains | 2 years ago |
Evaxion AEVAX | 2 | Buy | $1,100.00 | N/A | Maintains | 3 years ago |
Notable Labs LtdNTBLQ | 1 | Buy | $5.50 | N/A | Assumes | 3 years ago |
Rain Oncology IncRAIN2 | 1 | Buy | $15.00 | N/A | Initiates Coverage On | 3 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.